This browser doesn't support Spotify Web Player. Switch browsers or download Spotify for your desktop.

ESMO Open

By talk medicine

ESMO Open is the European Society for Medical Oncology’s online-only, peer-reviewed Open Access journal, dedicated to publishing high-quality medical research and educational content from all disciplines of oncology, with a focus on innovative clinical and translational cancer research. The journal is published by BMJ on behalf of ESMO. http://esmoopen.bmj.com/ * The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

  1. 1.
    ESMO-Magnitude of Clinical Benefit Scale (V1.1) for early breast cancer therapies07/20/2020
    15:00
  2. 2.
    ESMO-Magnitude of Clinical Benefit Scale of adjuvant colon cancer trials and meta-analyses06/28/2020
    7:34
  3. 3.
    Adjuvant and neoadjuvant therapies in melanoma06/04/2020
    12:32
  4. 4.
    Emerging targets in cancer immunotherapy04/05/2020
    7:59
  5. 5.
    News in breast cancer 201904/05/2020
    13:36
  6. 6.
    Cancer care during the spread of Covid-19 in Italy: a young oncologist's perspective03/25/2020
    10:55
  7. 7.
    ESMO Presidential Symposium: ClarIDHy - ivosidenib in patients with advanced cholangiocarcinoma02/12/2020
    7:01
  8. 8.
    News on the horizon in glioblastoma therapy01/29/2020
    12:13
  1. 9.
    Highlights in Lung Cancer 201912/20/2019
    26:44
  2. 10.
    Current biomarkers in immunotherapy10/03/2019
    4:47
  3. 11.
    ESMO Presidential Symposium: Final overall survival analysis from the FLAURA trial09/26/2019
    6:30
  4. 12.
    ESMO Presidential Symposium: Phase III PAOLA-1: Olaparib in newly diagnosed, advanced ovarian cancer09/24/2019
    5:39
  5. 13.
    Reimbursement Reality for Off-label use (OLU) of Drug Treatments in Cancer Care09/22/2019
    18:21
  6. 14.
    The ESMO-Magnitude of Clinical Benefit Scale Group09/09/2019
    16:20
  7. 15.
    What is new on the horizon in Melanoma Brain Metastasis?08/09/2019
    7:01
  8. 16.
    ESMO 2018 Presidential Symposium – IMpassion130: Atezolizumab in triple negative breast cancer10/04/2018
    9:10
  9. 17.
    ESMO 2018 Presidential Symposium: radiotherapy to the primary tumor in metastatic prostate cancer10/03/2018
    6:24
  10. 18.
    The Metastatic Breast Cancer project: a novel patient-partnered initiative09/05/2018
    26:54
  11. 19.
    Biosimilars in oncology07/24/2018
    9:49
  12. 20.
    Tumor evolution in non-small-cell lung cancer07/20/2018
    13:42
  13. 21.
    Immune checkpoint inhibitors for every non-small cell lung cancer patient07/17/2018
    16:38
  14. 22.
    Epigenetic Biomarkers in Cancer06/26/2018
    9:45
  15. 23.
    Questions asked in everyday practice: Immune Checkpoint Inhibitors06/04/2018
    14:38
  16. 24.
    Macrophage repolarization therapy in colorectal cancer05/23/2018
    15:14
  17. 25.
    New therapeutic anti-CEA anti-CD3 bispecific antibody in colorectal cancer04/16/2018
    21:03
  18. 26.
    Recent advances in adjuvant therapy for melanoma patients02/01/2018
    10:03
  19. 27.
    New therapeutic targets in the inflammatory microenvironment09/05/2017
    7:58
  20. 28.
    Immunotherapy in lung cancer07/26/2017
    16:01
  21. 29.
    ESMO Leaders Generation Programme – an alumni insight06/26/2017
    8:27
  22. 30.
    Heterogeneity of colon cancer: from bench to bedside06/14/2017
    18:02
  23. 31.
    ASCO - Practice changing studies in gastrointestinal cancer04/04/2017
    10:27
  24. 32.
    New horizons in breast cancer therapy - ESMO congress, ASCO and San Antonio Symposium’s highlights01/27/2017
    17:54
  25. 33.
    Tumor Network in Glioma11/08/2016
    7:44
  26. 34.
    Highlights in breast cancer from ASCO 201609/15/2016
    17:14
  27. 35.
    ASCO Highlights podcast: Head and neck cancers07/20/2016
    8:20
  28. 36.
    Highlights from the European Lung Cancer Conference (ELCC) 201605/10/2016
    5:27
  29. 37.
    The Cancer Genome - Highlights of a Nature Medicine Perspective04/11/2016
    10:40
  30. 38.
    Highlights from the ESMO Symposium on Signalling Pathways in Cancer 201604/04/2016
    11:42
  31. 39.
    Highlights from the Gastrointestinal Cancers Symposium02/17/2016
    9:42
  32. 40.
    Highlights from San Antonio Breast Cancer Symposium 201501/12/2016
    16:08

Listen to ESMO Open now.

Listen to ESMO Open in full in the Spotify app